156 related articles for article (PubMed ID: 20190247)
1. The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study.
Covic A; Mircescu G
Nephrol Dial Transplant; 2010 Aug; 25(8):2722-30. PubMed ID: 20190247
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemia.
Steinmetz T; Tschechne B; Harlin O; Klement B; Franzem M; Wamhoff J; Tesch H; Rohrberg R; Marschner N
Ann Oncol; 2013 Feb; 24(2):475-482. PubMed ID: 23071262
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of ferric carboxymaltose compared to iron sucrose in women with iron deficiency anemia: phase IV clinical trials.
Naqash A; Ara R; Bader GN
BMC Womens Health; 2018 Jan; 18(1):6. PubMed ID: 29304848
[TBL] [Abstract][Full Text] [Related]
4. A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients.
Bhandari S; Kalra PA; Kothari J; Ambühl PM; Christensen JH; Essaian AM; Thomsen LL; Macdougall IC; Coyne DW
Nephrol Dial Transplant; 2015 Sep; 30(9):1577-89. PubMed ID: 25925701
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ferric carboxymaltose on haemoglobin response among older patients with gastrointestinal bleeding: a randomised clinical trial.
Richard N; Arab-Hocine N; Vannier M; Leblanc-Boubchir R; Pelaquier A; Boruchowicz A; Musikas M; Amil M; Fumery M; Nahon S; Arotcarena R; Gelsi E; Maurin A; Hébuterne X; Savoye G
Age Ageing; 2024 May; 53(5):. PubMed ID: 38706390
[TBL] [Abstract][Full Text] [Related]
6. Ferric carboxymaltose vs. ferrous sulfate for the treatment of anemia in advanced chronic kidney disease: an observational retrospective study and cost analysis.
Cirillo L; Somma C; Allinovi M; Bagalà A; Ferro G; Di Marcantonio E; Bellelli S; Dallari LA; Ballo P; Dattolo PC
Sci Rep; 2021 Apr; 11(1):7463. PubMed ID: 33811227
[TBL] [Abstract][Full Text] [Related]
7. Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose.
Toblli JE; Angerosa M
Drug Des Devel Ther; 2014; 8():2475-91. PubMed ID: 25525337
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled, open label non-inferiority trial of intravenous ferric carboxymaltose versus iron sucrose in patients with iron deficiency anemia in China.
Jin J; Ran Z; Noseda E; Roubert B; Marty M; Mezzacasa A; Göring UM
Front Med; 2024 Feb; 18(1):98-108. PubMed ID: 37897561
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
Howaldt S; Domènech E; Martinez N; Schmidt C; Bokemeyer B
Inflamm Bowel Dis; 2022 Mar; 28(3):373-384. PubMed ID: 33988236
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of ferric carboxymaltose versus other intravenous iron preparations for the management of iron deficiency anemia during pregnancy.
Gupte S; Mukhopadhyay A; Puri M; Gopinath PM; Wani R; Sharma JB; Swami OC
Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765534
[TBL] [Abstract][Full Text] [Related]
11. Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis.
Rogozińska E; Daru J; Nicolaides M; Amezcua-Prieto C; Robinson S; Wang R; Godolphin PJ; Saborido CM; Zamora J; Khan KS; Thangaratinam S
Lancet Haematol; 2021 Jul; 8(7):e503-e512. PubMed ID: 34171281
[TBL] [Abstract][Full Text] [Related]
12. Intravenous ferric carboxymaltose for the management of iron deficiency and iron deficiency anaemia in children and adolescents: a review.
Aksan A; Zepp F; Anand S; Stein J
Eur J Pediatr; 2022 Nov; 181(11):3781-3793. PubMed ID: 36056175
[TBL] [Abstract][Full Text] [Related]
13. Single-dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF).
Yeo TJ; Yeo PSD; Hadi FA; Cushway T; Lee KY; Yin FF; Ching A; Li R; Loh SY; Lim SL; Wong RC; Tai BC; Richards AM; Lam CSP
ESC Heart Fail; 2018 Apr; 5(2):344-353. PubMed ID: 29345426
[TBL] [Abstract][Full Text] [Related]
14. One-Bag 8-Step Ferric Carboxymaltose Desensitization Protocol for Patients with a History of Hypersensitivity Reactions to Iron Preparations.
Özden Ş; Tepetam FM; Atik Ö
Int Arch Allergy Immunol; 2024; 185(5):449-455. PubMed ID: 38272014
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Intravenous Ferric Carboxymaltose Treatment of Iron Deficiency Anaemia in Patients with Corpus Atrophic Gastritis: A Retrospective Study.
Dottori L; Corleone Tsar'kov D; Dilaghi E; Pivetta G; Scalamonti S; Ligato I; Esposito G; Annibale B; Lahner E
Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836482
[TBL] [Abstract][Full Text] [Related]
16. Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia.
Korczowski B; Farrell C; Falone M; Blackman N; Rodgers T
Pediatr Res; 2023 Oct; 94(4):1547-1554. PubMed ID: 37208431
[TBL] [Abstract][Full Text] [Related]
17. The differential effect of modern intravenous iron on fibroblast growth factor 23 and phosphate in non-dialysis dependent CKD - the exploratory randomized controlled double-blind ExplorIRON-CKD study.
Kassianides X; Bhandari S
BMC Nephrol; 2024 Feb; 25(1):54. PubMed ID: 38347520
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
Derman R; Roman E; Modiano MR; Achebe MM; Thomsen LL; Auerbach M
Am J Hematol; 2017 Mar; 92(3):286-291. PubMed ID: 28052413
[TBL] [Abstract][Full Text] [Related]
19. Protocol for a multicentre, parallel-group, open-label randomised controlled trial comparing ferric carboxymaltose with the standard of care in anaemic Malawian pregnant women: the REVAMP trial.
Mwangi MN; Mzembe G; Moya E; Braat S; Harding R; Robberstad B; Simpson J; Stones W; Rogerson S; Biselele K; Chinkhumba J; Larson L; Ataíde R; Phiri KS; Pasricha SR
BMJ Open; 2021 Nov; 11(11):e053288. PubMed ID: 34815287
[TBL] [Abstract][Full Text] [Related]
20. Clinical effectiveness of ferric carboxymaltose (iv) versus iron sucrose (iv) in treatment of iron deficiency anaemia in pregnancy: A systematic review and meta-analysis.
Srimathi G; Revathy R; Bagepally BS; Joshi B
Indian J Med Res; 2024 Jan; 159(1):62-70. PubMed ID: 38439125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
